Delivery Order SPE2DB20D1100-SPE2DB24FC7X9

Award Date 7/17/24
Potential Completion Date 7/18/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,571.49 for the supply of Fluticasone Prop HFA 110 MCG 12GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, with an ultimate completion date of August 9, 2024. The contract is a Firm Fixed Price arrangement. Amerisourcebergen is supplying this pharmaceutical product as part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a $2,152.42 Firm Fixed Price Delivery Order for the supply of FLUTICASONE PROP HFA 220 MCG 12GM pharmaceutical products. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 11, 2024. This contract is not designated as a set-aside and serves as a delivery vehicle for Amerisourcebergen to provide a range of essential...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office division is a $3,492.36 Firm Fixed Price Delivery Order contract to provide the Defense Logistics Agency (DLA) with the pharmaceutical product Fluticasone Prop HFA 220 MCG 12GM. The award has an ultimate completion date of August 6, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with the DLA...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Fluticasone Prop HFA 110 MCG 12GM. The $1,538.89 firm fixed-price delivery order has a period of performance through February 6, 2025 and does not have any set-aside designation. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a major pharmaceutical distributor, is for the delivery of Fluticasone Prop HFA 220 MCG 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,947.32 firm fixed-price delivery order contract has a completion date of November 21, 2023. Amerisourcebergen is the prime contractor, and the contract is not designated with a set-aside. The company also holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product "FLUTICASONE PROP HFA 44 MCG 10.6GM." The contract, valued at $1,368.96, is a firm-fixed-price delivery order issued by the Defense Logistics Agency (DLA), a defense agency. The award has no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product - Fluticasone Prop HFA 110 MCG 12GM. The contract has a potential value of $3,937.85 and a completion date of February 20, 2024. Amerisourcebergen Drug Corp serves as a prime contractor providing a wide range of pharmaceuticals and medical supplies to U.S. government agencies, notably the Department of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of the pharmaceutical product Fluticasone Prop HFA 110 MCG 12GM. The $1,442.56 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on July 15, 2024, with a completion date of July 16, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the for-profit global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a potential value of $2,256.19 and a completion date of February 6, 2024. It is for the provision of Fluticasone Prop HFA 110 MCG 12GM, a pharmaceutical product. Amerisourcebergen Drug Corp is the prime contractor on this award, which is not...
The U.S. Defense Logistics Agency (DLA) awarded a $2,008.49 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of Fluticasone Propionate HFA 220 MCG 12GM, a pharmaceutical product. The contract has a period of performance through September 12, 2024 and does not utilize a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical and medical products to the federal government, holding several Indefinite Delivery...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7X9
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp's Corporate Office division is a delivery order valued at $1,307.59 for the supply of the pharmaceutical product fluticasone prop HFA 44 mcg 10.6 gm. The award was made by the Defense Logistics Agency (DLA), a defense agency, with a period of performance through July 2024. The contract is for firm fixed-price delivery of this pharmaceutical item and does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, leveraging its extensive supply chain to provide a wide range of essential medications and materials to military treatment facilities, veterans' hospitals, and other federal healthcare providers. The company holds several large indefinite delivery contracts (IDCs) with the DLA and other agencies for the ongoing supply of these critical medical commodities.

Generated 10/16/24, 9:17 AM